课题基金 / 基金详情

ORAL RS-25560-197 SUSPENSION IN PATIENTS WITH CONGESTIVE HEART FAILURE

ORAL RS-25560-197 SUSPENSION IN PATIENTS WITH CONGESTIVE HEART FAILURE
充血性心力衰竭患者口服 RS-25560-197 暂停
批准号：
6274712
负责人：
JOHN M NICKLAS
金额：
$2.15万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6274712
关键词：
clinical research congestive heart failure dosage drug screening /evaluation heart disorder chemotherapy heart pharmacology human subject human therapy evaluation oral administration pharmacokinetics placebos

项目摘要

项目成果

JOHN M NICKLAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study is a double-blind placebo-controlled study to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple dose (10-day) administration of an oral RS-25560-197 suspension in patients with congestive heart failure.ith congestive heart failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRK820 IN PATIENTS WITH HYPONATREMIA COINCIDENT WITH CONGESTIVE HEART FAILURE
EXERCISE EFFECTS ON LEFT VENTRICULAR FUNCTION IN CONGESTIVE HEART FAILURE
TRK820 IN PATIENTS WITH HYPONATREMIA COINCIDENT WITH CONGESTIVE HEART FAILURE
EXERCISE EFFECTS ON LEFT VENTRICULAR FUNCTION IN CONGESTIVE HEART FAILURE
海外基金